Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Episode | Date |
---|---|
Drug Development in Obesity
|
Apr 30, 2024 |
The Current Dynamics in Capital Markets
|
Apr 15, 2024 |
Vaccine Developments 2024: A Podcast Discussion on Latest Vaccine Technology and Ongoing Clinical Developments
|
Mar 18, 2024 |
Trends and Investment Activity in Radiopharmaceuticals and Psychedelics
|
Feb 14, 2024 |
Vertex’s Exa-cel to Biogen and Sage’s Zurzuvae: Notable Product Approvals of 2023
|
Jan 03, 2024 |
Monthly Roundup of News from Healthcare Development
|
Nov 07, 2023 |
The Current and Future Landscape of Healthcare IPO Markets
|
Oct 27, 2023 |
The Heart of the Matter: Behind the Renewed Interest in Cardiovascular Disease
|
Oct 12, 2023 |
The Transactional Landscape Of ADCs: The Powerhouse of Antibody Drug Conjugates
|
Aug 29, 2023 |
Investing in Health Tech & Digital Medicine: Expert Talk with Mikaela Odlander & Edward Kliphuis
|
Apr 14, 2023 |
Contingencies for Biopharma, Medtech Deal Planning in a Down Market
|
Feb 09, 2023 |
Gene Editing to Cross-Species Transplantation: The Most Compelling Healthcare Stories of 2022
|
Jan 24, 2023 |
Preparing BioPharma and Medtech Companies for Public Listing - Back Bay Life Science Advisors and Nasdaq Nordic
|
Sep 19, 2022 |
The Promising Field of Targeted Protein Degraders (TPDs)
|
Jul 30, 2022 |
Early Market Access and Pricing with Pete Bak, Christian Thieniel and Brendan Wang
|
Jul 06, 2022 |
Living Medicines – Current and Future Uses of Car T Cells with Peter Bak, PhD and Mike Bogetofte Barnkob, MD, PhD
|
May 19, 2022 |
The Evolving Regulatory Framework for Novel Medicines in the EU
|
Apr 25, 2022 |
The Commercial Potential of Optogenetic Therapies
|
Mar 15, 2022 |
The Latest on Antibiotic Development, Back Bay Life Science Advisors with Antabio
|
Jan 19, 2022 |
Best Practices for Successful Sell-Side Licensing, Partnering and M&A
|
Jan 07, 2022 |
Cell and Gene Therapy Investment Trends
|
Nov 22, 2021 |
MedTech Investing with Paul LaViolette of SV Health Investors and Jonathan P. Gertler, MD, Back Bay Life Science Advisors and BioVentures Medtech Funds
|
Oct 13, 2021 |
Remote Patient Monitoring
|
Aug 05, 2021 |
New Drug Pricing and Market Access
|
Jun 30, 2021 |
The Question of Investment in Antimicrobials
|
Jun 11, 2021 |
Life Science SPACs: A Forward Look at this Evolving Asset Class
|
Jun 03, 2021 |
Gene Therapies: What’s to Come as The Industry Moves Forward
|
Jun 02, 2021 |